This episode currently has no reviews.
Submit ReviewWhether you think it is more like Facebook or LinkedIn, there’s no denying that Doximity is making a name for itself in digitizing the world of medicine. Join the Motley Fool’s Brian Feroldi and Emily Flippen as they break down this new healthcare IPO.
Stocks: Doximity (DOCS)
Check out more of our content here:
Reach us by Email @ IndustryFocus@fool.com
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review